Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
3.230
-0.720 (-18.23%)
At close: Mar 31, 2025, 4:00 PM
3.378
+0.148 (4.57%)
Pre-market: Apr 1, 2025, 5:26 AM EDT

Telomir Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
96123---
Enterprise Value
95122---
Last Close Price
3.234.12---
PB Ratio
149.50190.63---
P/TBV Ratio
190.63190.63---
Debt / Equity Ratio
0.140.140.18-0.62-0.86
Quick Ratio
1.861.860.000.00-
Current Ratio
1.941.940.330.05-
Return on Equity (ROE)
-810.18%-810.18%-1045.36%--
Return on Assets (ROA)
-250.96%-250.96%-102.18%--
Return on Capital (ROIC)
-318.60%-318.60%-132.78%--
Earnings Yield
-17.20%-13.49%---
Buyback Yield / Dilution
-8.18%-8.18%-1.77%--
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q